CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...